Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD1 | O95696 | 7/20 | 0.32 |
| ▸ | BRPF1 | P55201 | 7/20 | 0.32 |
| ▸ | TAF1 | P21675 | 6/20 | 0.32 |
| ▸ | BRD4 | O60885 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16728719 | 0.77 | SMN1; SMN2 (0.42) | — | |
| SCHEMBL20865196 | 0.74 | — | — | |
| SCHEMBL20201467 | 0.70 | ADRB1 (0.43) | CYP2C19HTT | |
| SCHEMBL20865060 | 0.70 | ALDH1A1 (0.34) | BRD1BRPF1TAF1BRD4 | |
| SCHEMBL10988134 | 0.68 | ALDH1A1 (0.37) | BRD4CYP1A2HTT | |
| SCHEMBL8334894 | 0.68 | GSK3A (0.38) | BRPF1BRD4 | |
| SCHEMBL17173250 | 0.68 | CASP3 (0.39) | — | |
| SCHEMBL30304280 | 0.68 | RAB9A (0.43) | CYP1A2 | |
| SCHEMBL14675416 | 0.67 | MGLL (0.43) | — | |
| Iodide SCHEMBL15993211 | 0.67 | GSK3A (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190100544-A1 | ORGANIC LUMINESCENT MATERIALS CONTAINING TETRAPHENYLENE LIGANDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190100544-A1 | ORGANIC LUMINESCENT MATERIALS CONTAINING TETRAPHENYLENE LIGANDS | EML4, PML, OCIAD2 | BRD1 3953/4885BRPF1 1473/4885TAF1 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.